Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
CytoDyn Inc. is a biotechnology company focused on developing innovative treatments, primarily through its monoclonal antibody leronlimab targeting CCR5. Its research targets cancer, HIV, COVID-19, and inflammatory diseases, emphasizing clinical trials and regulatory approval. The company aims to leverage its proprietary technology, patents, and strategic partnerships to bring targeted biologic therapies to global markets.
This description was generated via AI from an annual report. Updated about 1 year ago.